Citadel Advisors
SZYM

Citadel Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Citadel Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-33,700
Closed -$84K – 9007
2015
Q4 		$84K Buy
33,700
+5,300
+19% +$15.7K ﹤0.01% 6867
2015
Q3 		$74K Sell
28,400
-71,300
-72% -$186K ﹤0.01% 7255
2015
Q2 		$313K Buy
99,700
+49,500
+99% +$170K ﹤0.01% 5687
2015
Q1 		$144K Sell
50,200
-44,700
-47% -$114K ﹤0.01% 6536
2014
Q4 		$245K Buy
94,900
+56,200
+145% +$246K ﹤0.01% 5723
2014
Q3 		$289K Buy
38,700
+9,800
+34% +$91.5K ﹤0.01% 5307
2014
Q2 		$340K Sell
28,900
-25,000
-46% -$267K ﹤0.01% 4884
2014
Q1 		$626K Buy
53,900
+700
+1% +$8.24K ﹤0.01% 4034
2013
Q4 		$579K Buy
53,200
+15,100
+40% +$149K ﹤0.01% 3840
2013
Q3 		$410K Buy
38,100
+6,100
+19% +$69.5K ﹤0.01% 4023
2013
Q2 		$375K Buy
+32,000
New +$320K ﹤0.01% 4105

Citadel Advisors's SZYM Position: Q2 2016 in Review

Citadel Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 47,587 shares — an estimated $97K sold.

Citadel Advisors first reported a position in SZYM in Q2 2013 and held it in 10 quarters. The position peaked at $678K in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Citadel Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Citadel Advisors sold 47,587 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $97K.
  • Citadel Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 10 quarters.
  • Citadel Advisors's SOLAZYME INC COM STK (DE) position peaked at $678K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.